Shilpa Gupta, Director of Genitourinary Oncology at the Cleveland Clinic, shared a post on LinkedIn:
“Honored to be in Beijing as a keynote speaker at the 4th Clinical Research UroOnc Conference, hosted by Dr. Jun Gao (PI, DV–toripalimab in 1L mUC; The New England Journal of Medicine 2025).
What stood out was the pace and scale of clinical research across GU cancers, especially the rapid progress in ADC–IO combinations in bladder cancer. The depth of innovation and execution in China is actively reshaping the global clinical trial landscape.
Also had the opportunity to tour their new hospital with truly state-of-the-art clinical trials infrastructure.
Grateful for the warm hospitality and the chance to collaborate with colleagues advancing progress and helping close gaps in global access and disparities.
An added privilege was to visit the Great Wall of China, reminder of history, scale, and perspective.”
Other article featuring Shilpa Gupta on OncoDaily.
